Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Bioenvision obtains clofarabine option in Japan and South East Asia

Sep. 16, 2003

Philip Morris grant supports TNT-based lung cancer research

Sep. 16, 2003

Vitaxin enters phase II trials in melanoma and rheumatoid arthritis

Sep. 16, 2003

Antisoma licenses telomerase inhibitor program

Sep. 16, 2003

Kinase inhibitors under study at Bayer

Sep. 16, 2003

Preclinical results reported for AZ-CINN-310 in breast cancer

Sep. 16, 2003

Phase III results for Genasense plus chemotherapy in malignant melanoma

Sep. 15, 2003

Javlor enters two new phase III trials in NSCLC and bladder cancer

Sep. 15, 2003

OncoGenex and Isis expand antisense drug development partnership

Sep. 15, 2003

Rexin-G designated an orphan drug for pancreatic cancer

Sep. 12, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...